We are live on ! Find out more
BPBT

Boston Private Bank & Trust Portfolio holdings

AUM $2.17B
1-Year Est. Return 12.34%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+12.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.06B
AUM Growth
+$87.7M
Cap. Flow
+$7.09M
Cap. Flow %
0.34%
Top 10 Hldgs %
16.96%
Holding
1,082
New
62
Increased
240
Reduced
307
Closed
89

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$8.01M
2
MRO
Marathon Oil Corporation
MRO
+$5.88M
3
MRK icon
Merck
MRK
+$5.24M
4
JPM icon
JPMorgan Chase
JPM
+$4.96M
5
ABT icon
Abbott
ABT
+$3.12M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$6.72M
2
A icon
Agilent Technologies
A
+$5.13M
3
XOM icon
ExxonMobil
XOM
+$4.68M
4
HSBC icon
HSBC
HSBC
+$4.54M
5
IBM icon
IBM
IBM
+$3.37M

Sector Composition

Rank Sector Weight
1 Healthcare 16.27%
2 Technology 13.16%
3 Industrials 11.32%
4 Energy 11.1%
5 Financials 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNR icon
726
Pentair
PNR
$10.9B
$22K ﹤0.01%
451
XLI icon
727
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
$22K ﹤0.01%
400
+100
+33% +$5.34K
MCA
728
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$22K ﹤0.01%
1,505
BITA
729
DELISTED
Bitauto Holdings Limited
BITA
$22K ﹤0.01%
449
APU
730
DELISTED
AmeriGas Partners, L.P.
APU
$22K ﹤0.01%
474
GPN icon
731
Global Payments
GPN
$24.1B
$21K ﹤0.01%
590
HASI icon
732
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.97B
$21K ﹤0.01%
1,460
+710
+95% +$9.87K
STZ icon
733
Constellation Brands
STZ
$22.4B
$21K ﹤0.01%
237
VRSK icon
734
Verisk Analytics
VRSK
$25.1B
$21K ﹤0.01%
+350
New +$20.9K
ORAN
735
DELISTED
Orange
ORAN
$21K ﹤0.01%
+1,304
New +$20.9K
BMRN icon
736
BioMarin Pharmaceuticals
BMRN
$11.7B
$20K ﹤0.01%
+325
New +$19.6K
E icon
737
ENI
E
$77.5B
$20K ﹤0.01%
+363
New +$18.8K
FLS icon
738
Flowserve
FLS
$10.2B
$20K ﹤0.01%
264
GM icon
739
General Motors
GM
$77.5B
$20K ﹤0.01%
550
-1
-0.2% -$35
HAS icon
740
Hasbro
HAS
$12.9B
$20K ﹤0.01%
378
PRI icon
741
Primerica
PRI
$9.92B
$20K ﹤0.01%
415
+75
+22% +$3.44K
VIV icon
742
Telefônica Brasil
VIV
$19.7B
$20K ﹤0.01%
+973
New +$20.1K
SFLY
743
DELISTED
Shutterfly, Inc.
SFLY
$20K ﹤0.01%
455
+150
+49% +$6.14K
ICON
744
DELISTED
Iconix Brand Group, Inc.
ICON
$20K ﹤0.01%
47
+13
+38% +$5.36K
CRL icon
745
Charles River Laboratories
CRL
$11.3B
$19K ﹤0.01%
350
CW icon
746
Curtiss-Wright
CW
$28B
$19K ﹤0.01%
+296
New +$19.4K
EC icon
747
Ecopetrol
EC
$33.5B
$19K ﹤0.01%
+538
New +$20.3K
FSP
748
Franklin Street Properties
FSP
$48.4M
$19K ﹤0.01%
+1,500
New +$18.6K
MYGN icon
749
Myriad Genetics
MYGN
$303M
$19K ﹤0.01%
500
TTC icon
750
Toro Company
TTC
$9.44B
$19K ﹤0.01%
600

Similar funds

Boston Private Bank & Trust's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Private Bank & Trust held 1,082 positions worth $2.06B, up 4.4% from $1.97B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Private Bank & Trust's Q2 2014 filing shows 62 new, 240 increased, 307 reduced and 89 closed positions. Its largest new stake was Keurig Dr Pepper: 6,085 shares worth $356K. The largest sale was Novartis, an estimated $6.72M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • Boston Private Bank & Trust's largest Q2 2014 buy was Keurig Dr Pepper: 6,085 shares worth $356K.
  • Boston Private Bank & Trust added most to Walmart Inc in Q2 2014, an estimated $8.01M increase.
  • Boston Private Bank & Trust's biggest Q2 2014 reduction was Novartis, cutting an estimated $6.72M.
  • Boston Private Bank & Trust fully exited Weatherford International plc in Q2 2014, selling an estimated $1.03M.
  • Boston Private Bank & Trust's ten largest holdings make up 17% of its $2.06B portfolio in Q2 2014.
  • Boston Private Bank & Trust opened 62 new positions and closed 89 in Q2 2014.
  • Boston Private Bank & Trust's portfolio value rose 4.4% quarter-over-quarter to $2.06B.

Based on Boston Private Bank & Trust's 13F filing for Q2 2014, filed 15 Jul 2014.